European Addiction Research

 

Steps towards Constructing a Global Comparative Risk Analysis for Alcohol Consumption: Determining Indicators and Empirical Weights for Patterns of Drinking, Deciding about Theoretical Minimum, and Dealing with Different Consequences

Rehm J.a-c · Monteiro M.d · Room R.e · Gmel G.f · Jernigan D.g · Frick U.h · Graham K.b

Author affiliations

aAddiction Research Institute, Zürich, Switzerland; bCentre for Addiction and Mental Health, Toronto, Ont.; cUniversity of Toronto, Ont., Canada; dWorld Health Organization, Geneva, Switzerland; eCentre for Social Research on Alcohol and Drugs, Stockholm University, Stockholm, Sweden; fSwiss Institute for the Prevention of Alcohol and Other Drug Problems, Lausanne, Switzerland; gMarin Institute for the Prevention of Alcohol and Other Drug Problems, San Rafael, Calif., USA, and hUniversity of Regensburg, Germany

Related Articles for ""

Eur Addict Res 2001;7:138–147

Log in to MyKarger to check if you already have access to this content.


Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!


If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.

Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select
* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Paper

Published online: August 08, 2001
Issue release date: August 2001

Number of Print Pages: 10
Number of Figures: 1
Number of Tables: 4

ISSN: 1022-6877 (Print)
eISSN: 1421-9891 (Online)

For additional information: https://www.karger.com/EAR

Abstract

In order to conduct a comparative risk analysis for alcohol within the Global Burden of Disease Study (GBD 2000), several questions had to be answered. (1) What are the appropriate dimensions for alcohol consumption and how can they be categorized? The average volume of alcohol and patterns of drinking were selected as dimensions. Both dimensions could be looked upon as continuous but were categorized for practical purposes. The average volume of drinking was categorized into the following categories: abstention; drinking 1 (>0–19.99 g pure alcohol daily for females, >0–39.99 g for males); drinking 2 (20–39.99 g for females, 40–59.99 g for males), and drinking 3 (≧40 g for females, ≧60 g for males). Patterns of drinking were categorized into four levels of detrimental impact based on an optimal scaling analysis of key informant ratings. (2) What is the theoretical minimum for both dimensions? A pattern of regular light drinking (at most 1 drink every day) was selected as theoretical minimum for established market economies for all people above age 45. For all other regions and age groups, the theoretical minimum was set to zero. Potential problems and uncertainties with this selection are discussed. (3) What are the health outcomes for alcohol and how do they relate to the dimensions? Overall, more than 60 disease conditions were identified as being related to alcohol consumption. Most chronic conditions seem to be related to volume only (exceptions are coronary heart disease and ischemic stroke), and most acute conditions seem to be related to volume and patterns. In addition, using methodology based on aggregate data, patterns were relevant for attributing harms for men but not women.

© 2001 S. Karger AG, Basel




Related Articles:


References

  1. English DR, Holman CDJ, Milne E, Winter MJ, Hulse GK, Codde G, Bower CI, Cortu B, de Klerk N, Lewin GF, Knuiman M, Kurinczuk JJ, Ryan, GA: The Quantification of Drug Caused Morbidity and Mortality in Australia 1995. Canberra, Commonwealth Department of Human Services and Health, 1995.
  2. Single E, Robson L, Rehm J, Xie X: Morbidity and mortality attributable to alcohol, tobacco, and illicit drug use in Canada. Am J Public Health 1999;89:385–390.
  3. Gutjahr E, Gmel G, Rehm J: The relation between average alcohol consumption and disease: An overview. Eur Addict Res 2001;7:117–127.
  4. Rehm J, Ashley MJ, Room R, Single E, Bondy SJ, Ferrence R, et al: Drinking patterns and their consequences: Report from an international meeting. Addiction 1996;91:1615–1621.
  5. Mc Elduff P, Dobson AJ: How much alcohol and how often? Population-based case-control study of alcohol consumption and risk of a major coronary event. Br Med J 1997;314:1159–1164.
  6. Bondy SJ: Drinking patterns and their consequences: Report from an international meeting – Overview of studies on drinking patterns and consequences. Addiction 1996;91:1663–1674.
  7. Puddey IB, Rakic V, Dimmitt SB, Beilin LJ: Influence of pattern of drinking on cardiovascular disease and cardiovascular risk factors – A review. Addiction 1999;94:649–663.
  8. Room R, Carlini Cotrim B, Gureje O, Jernigan D, Mäkelä K, Marshall M, Medina-Mora ME, Monteiro M, Parry C, Partanen J, Riley L, Saxena S: Alcohol in a Changing World: Drinking Patterns and Problems in Developing Societies. Cambridge, Cambridge University Press, in press.
  9. Rehm J, Gmel G: Gaps and needs in international alcohol epidemiology. J Subst Use 2000;5:6–13.
    External Resources
  10. Gmel G, Rehm J, Frick U: Methodological approaches to conducting pooled cross-sectional time series analysis: the example of the EU states. Eur Addict Res 2001;7:128–137.
  11. Simpura J: Trends in alcohol consumption and drinking patterns: Sociological and economic explanations and alcohol policies. Nord Stud Alcohol Drugs 2001;18(English suppl):3–13.
  12. Room R: The impossible dream? Routes to reducing alcohol problems in a temperance culture. J Subst Abuse 1992;4:91–106.
  13. Single E, Robson L, Xie X, Rehm J, in collaboration with Moore R, et al: The Costs of Substance Abuse in Canada. Ottawa, Canadian Centre on Substance Abuse, 1996.
  14. Murray CJL, Lopez A: On the comparable quantification of health risks: Lessons from the Global Burden of Disease Study. Epidemiology 1999,10:594–605.
  15. Rehm J, Gmel G, Room R, Frick U: Average volume of alcohol consumption, drinking patterns and related burden of mortality in young people in established market economies of Europe. Eur Addict Res 2001;7:148–151.
  16. Holman CDAJ, English DR, Milne E, Winter MG: Meta-analysis of alcohol and all-cause mortality: A validation of NHMRC recommendations. Med J Aust 1996;164:141–145.
  17. Trotter RT, Rehm J, Chatterji S, Room R, Üstün TB: Cross-Cultural Applicability Research (CAR) Methods; in Üstün TB, Chatterji S, Bickenbaach JE, Trotter RT, Room R, Rehm J, Saxena S (eds): Disability and Culture: Universalism and Diversity. Göttingen, Hogrefe & Huber, 2001.
  18. Bijleveld CCJH, van der Kamp LJT: Longitudinal Data Analysis: Designs, Models and Methods. London, Sage Press, 1998, pp 46–154.
  19. US Department of Health and Human Services: 10th Special Report to the US Congress on Alcohol and Health: Highlights from Current Research. Rockville, US Department of Health and Human Services, Public Health Service, National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism, 2000, vol 97, p 4017.
  20. Ahmad OB, Boschi-Pinto C, Lopez AD, Murray CJL, Lozano R, Inoue M: Age Standardization of Rates: A New WHO World Standard. GPE Discussion Paper Ser No. 31. Geneva, EIP/GPE/EBD World Health Organization, 2000.
  21. Segi, M. Cancer mortality for selected sites in 24 countries (1950–57). Sendai, Department of Public Health, Tohoku University of Medicine, 1960.
  22. World Health Organization: Global Status Report on Alcohol. Geneva, World Health Organization Substance Abuse Department, 1999.
  23. Rehm J, Greenfield TK, Rogers JD: Average volume of alcohol consumption, patterns of drinking and all-cause mortality. Results from the US National Alcohol Survey. Am J Epidemiol 2001;153:64–71.
    External Resources
  24. Murray CJL, Lopez A: The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries and Risk Factors in 1990 and Projected to 2020. Boston, Harvard School of Public Health on behalf of the World Health Organization and the World Bank, 1996.
  25. Chadwick DJ, Goode JA: Alcohol and Cardiovascular Diseases. Chichester, Wiley, 1999.
  26. Ashley MJ, Rehm J, Bondy S, Single E, Rankin J: Beyond ischemic heart disease: Are there other health benefits from drinking alcohol? Contemporary Drug Problems, in press.
  27. Rehm J, Gutjahr E, Gmel G: Alcohol and all-cause mortality: A pooled analysis. Contemporary Drug Problems, in press.
  28. Knupfer G: Drinking for health: The daily light drinker fiction. Br J Addict 1987;82:547–555.
    External Resources
  29. Rehm J, Sempos CT: Alcohol consumption and mortality – Questions about causality, confounding and methodology. Addiction 1995;90:493–498.
  30. Rehm J, Sempos CT: Alcohol consumption and all-cause mortality Addiction 1995;90:471–480.
  31. Feunekes GIJ, van’t Veer P, van Staveren WA, Kok F: Alcohol intake assessment: The sober facts. Am J Epidemiol 1999;150:105–112.
  32. Rehm J: Re: ‘Alcohol intake assessment: The sober facts’. Am J Epidemiol 2000;151:436–438.
  33. Walsh G, Rehm J: Daily drinking and harm. Contemporary Drug Problems 1996;23:465–478.
  34. Veenstra J, Ockhuizen T, van de Pol, Wedel M, Schaafsma G: Effects of moderate dose of alcohol on blood lipids and lipoproteins postprandially and in the fasting state. Alcohol 1990;25:371–377.
    External Resources
  35. Fahrenkrug H, Rehm J: Trinkkontexte und Freizeitaktivitäten in der Vorphase alkoholbezogener Strassenverkehrsunfälle junger Fahrerinnen und Fahrer in der Schweiz. Sucht 1994;41:169–180.

Article / Publication Details

First-Page Preview
Abstract of Paper

Published online: August 08, 2001
Issue release date: August 2001

Number of Print Pages: 10
Number of Figures: 1
Number of Tables: 4

ISSN: 1022-6877 (Print)
eISSN: 1421-9891 (Online)

For additional information: https://www.karger.com/EAR


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
TOP